“…Numerous studies have indicated the critical role for regulation of the intracellular Ca 2+ concentration in the pathogenesis of age-related neuronal dysfunction with a variety of techniques and human disease model systems (Landfield, 1987; Mattson and Chan, 2001; Mattson et al, 1989; Missiaen et al, 2000; Squier and Bigelow, 2000; Thibault et al, 1998). Perturbations in the intracellular Ca 2+ homoeostasis are often a result of oxidative stress and are typically correlated with deficits in nerve cell function, increased cell damage and cell death of neurons and require control of the intracellular Ca 2+ concentration to achieve improvement of the conditions (Baskys and Adamchik, 2001; Butterfield et al, 2001; Chen, 1998; Chen and Fernandez, 1999; Hall et al, 2001; Kontush, 2001; Leissring et al, 2000; Massheimer et al, 2000; Mattson and Chan, 2001; Mattson et al, 1989; Mattson et al, 2000; Missiaen et al, 2000; O'Neill et al, 2001; Squier and Bigelow, 2000; Thibault et al, 2001; Thibault et al, 1998; Tuppo and Forman, 2001; Veinbergs et al, 2002). IP 3 Rs are pivotal to the regulation of intracellular Ca 2+ and neuronal function (Berridge, 2009) and have been found involved in a variety of pathophysiological mechanisms, including those leading to AD (for review see, Stutzmann, 2005), by either direct or indirect modulation (Cheung et al, 2010; Crews et al, 1994; Ferrari-DiLeo and Flynn, 1993; Ferreiro et al, 2006; Garlind et al, 1995; Kasri et al, 2006; Kurumatani et al, 1998; Stokes and Hawthorne, 1987; Stutzmann et al, 2004; Young et al, 1988).…”